{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:44:52Z","timestamp":1793677492306,"version":"4.5.1"},"reference-count":56,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["HTA 12\/44"],"award-info":[{"award-number":["HTA 12\/44"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,9,12]]},"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To generate estimates of comparative clinical effectiveness for interventions used in the treatment of anogenital warts (AGWs) through the systematic review, appraisal and synthesis of data from randomised controlled trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and network meta-analysis of RCTs. Search strategies were developed for MEDLINE, Embase, the Cochrane Library and the Web of Science. For electronic databases, searches were run from inception to March 2018. The systematic review was carried out following the general principles recommended in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>People aged \u226516 years with clinically diagnosed AGWs (irrespective of biopsy confirmation).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Topical and ablative treatments recommended by the British Association for Sexual Health and HIV for the treatment of AGWs, either as monotherapy or in combination versus each other.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>Complete clearance of AGWs at the end of treatment and at other scheduled visits, and rate of recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-seven RCTs met inclusion criteria. Twenty studies were assessed as being at unclear risk of bias, with the remaining studies categorised as high risk of bias. Network meta-analysis indicates that, of the treatment options compared, carbon dioxide laser therapy is the most effective treatment for achieving complete clearance of AGWs at the end of treatment. Of patient-applied topical treatments, podophyllotoxin 0.5% solution was found to be the most effective at achieving complete clearance, and was associated with a statistically significant difference compared with imiquimod 5% cream and polyphenon E 10% ointment (p&lt;0.05). Few data were available on recurrence of AGWs after complete clearance. Of the interventions evaluated, surgical excision was the most effective at minimising risk of recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Of the studies assessed, as a collective, the quality of the evidence is low. Few studies are available that evaluate treatment options versus each other.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CRD42013005457<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-027765","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T07:01:50Z","timestamp":1572591710000},"page":"e027765","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"9","author":[{"given":"Samantha","family":"Barton","sequence":"first","affiliation":[{"name":"BMJ-Technology Assessment Group, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Wakefield","sequence":"additional","affiliation":[{"name":"BMJ-Technology Assessment Group, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"O'Mahony","sequence":"additional","affiliation":[{"name":"Nuffield Health, Chester, UK"},{"name":"Liverpool Medical Institution, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Edwards","sequence":"additional","affiliation":[{"name":"BMJ-Technology Assessment Group, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"2025121400191594000_9.10.e027765.1","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2025121400191594000_9.10.e027765.2","unstructured":"World Health Organisation . International agency for research on cancer. IARC monograph on the evaluation of carcinogenic risks to humans. Human Papillomaviruses, 2007. https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono90.pdf"},{"key":"2025121400191594000_9.10.e027765.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"2025121400191594000_9.10.e027765.4","unstructured":"Department of Health . Introduction of human papillomavirus vaccine into the National immunisation programme: announcement of vaccine to be used, 2008. Available: http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_085581.pdf [Accessed 24 Oct 2018]."},{"key":"2025121400191594000_9.10.e027765.5","unstructured":"Joint Committee on vaccination and immunisation. statement on HPV vaccination, 2018. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/726319\/JCVI_Statement_on_HPV_vaccination_2018.pdf [Accessed 29 Oct 2018]."},{"key":"2025121400191594000_9.10.e027765.6","doi-asserted-by":"crossref","unstructured":"Ali H , Donovan B , Wand H , et al . Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013;346.doi:10.1136\/bmj.f2032","DOI":"10.1136\/bmj.f2032"},{"key":"2025121400191594000_9.10.e027765.7","unstructured":"British association of sexual health and HIV. UK national guidelines on the management of anogenital warts, 2015. Available: https:\/\/www.bashhguidelines.org\/media\/1075\/uk-national-guideline-on-warts-2015-final.pdf [Accessed 29 Nov 2017]."},{"key":"2025121400191594000_9.10.e027765.8","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200106000-00007"},{"key":"2025121400191594000_9.10.e027765.9","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200202150-00017"},{"key":"2025121400191594000_9.10.e027765.10","doi-asserted-by":"publisher","DOI":"10.1086\/322593"},{"key":"2025121400191594000_9.10.e027765.11","doi-asserted-by":"publisher","DOI":"10.3310\/hta20220"},{"key":"2025121400191594000_9.10.e027765.12","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052768"},{"key":"2025121400191594000_9.10.e027765.13","unstructured":"Information Specialists\u2019 Sub-Group . The InterTASC Information Specialists\u2019 Sub-Group Search Filter Resource. Centre for Reviews and Dissemination, 2017. Available: https:\/\/sites.google.com\/a\/york.ac.uk\/issg-search-filters-resource\/home\/search-filters-by-design [Accessed 29 Nov 2017]."},{"key":"2025121400191594000_9.10.e027765.14","unstructured":"Centre for reviews and dissemination (CRD). CRD's guidance for undertaking reviews in healthcare, 2011. Available: https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf [Accessed 8 Nov 2018]."},{"key":"2025121400191594000_9.10.e027765.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2025121400191594000_9.10.e027765.16","doi-asserted-by":"crossref","unstructured":"Higgins JP , Green S . Cochrane handbook for systematic reviews of interventions. Wiley Online Library, 2008.","DOI":"10.1002\/9780470712184"},{"key":"2025121400191594000_9.10.e027765.17","unstructured":"Dias S , Welton NJ , Sutton AJ , et al . Nice dsu technical support document 1: introduction to evidence synthesis for decision making, 2012. Available: http:\/\/www.nicedsu.org.uk\/TSD1%20Introduction.final.08.05.12.pdf. [Accessed 7 Mar 2017]."},{"key":"2025121400191594000_9.10.e027765.18","unstructured":"Dias S , Welton NJ , Sutton AJ , et al . Nice dsu technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, 2016. Available: http:\/\/www.nicedsu.org.uk\/TSD2%20General%20meta%20analysis%20corrected%202Sep2016v2.pdf [Accessed 7 Mar 2017]."},{"key":"2025121400191594000_9.10.e027765.19","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-10-54","article-title":"Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial","volume":"10","author":"Woods","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"2025121400191594000_9.10.e027765.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2025121400191594000_9.10.e027765.21","first-page":"1710","article-title":"Comparing the efficacy of cryotherapy with 25% solution of podophyllin in the treatment of genital warts in women","volume":"33","author":"Kafaie","year":"2015","journal-title":"J Isfahan Med School"},{"key":"2025121400191594000_9.10.e027765.22","first-page":"393","article-title":"Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma","volume":"74","author":"Benedetti Panici","year":"1989","journal-title":"Obstet Gynecol"},{"key":"2025121400191594000_9.10.e027765.23","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.4.270"},{"key":"2025121400191594000_9.10.e027765.24","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912030-00011"},{"key":"2025121400191594000_9.10.e027765.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08520.x"},{"key":"2025121400191594000_9.10.e027765.26","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.038075"},{"key":"2025121400191594000_9.10.e027765.27","doi-asserted-by":"publisher","DOI":"10.1136\/sti.57.4.273"},{"key":"2025121400191594000_9.10.e027765.28","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2007.007196"},{"key":"2025121400191594000_9.10.e027765.29","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jog.12457","article-title":"Efficacy of combination therapy of oral zinc sulfate with imiquimod, podophyllin or cryotherapy in the treatment of vulvar warts","volume":"40","author":"Akhavan","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"2025121400191594000_9.10.e027765.30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(85)92677-7","article-title":"Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata","volume":"2","author":"Jensen","year":"1985","journal-title":"Lancet"},{"key":"2025121400191594000_9.10.e027765.31","first-page":"146","article-title":"Topical podophyllin and podophyllotoxin for treatment of genital warts : a comparative study","volume":"48","author":"Kar","year":"2003","journal-title":"Ind. J. Dermatol"},{"key":"2025121400191594000_9.10.e027765.32","first-page":"31","article-title":"Podophyllotoxin for treatment of genital warts in males. A comparison with conventional podophyllin therapy","volume":"2","author":"Lassus","year":"1984","journal-title":"Eur. J. Sex Transm. Dis"},{"key":"2025121400191594000_9.10.e027765.33","first-page":"67","article-title":"A comparative study of efficacy of imiquimod 5% versus podophyllin 20% in treatment of external and genital warts","volume":"27","author":"Padhiar","year":"2006","journal-title":"Indian J Sex Transm Dis"},{"key":"2025121400191594000_9.10.e027765.34","doi-asserted-by":"publisher","DOI":"10.1258\/0956462011923723"},{"key":"2025121400191594000_9.10.e027765.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2004.tb00568.x"},{"key":"2025121400191594000_9.10.e027765.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70243-9"},{"key":"2025121400191594000_9.10.e027765.37","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.1.25"},{"key":"2025121400191594000_9.10.e027765.38","doi-asserted-by":"publisher","DOI":"10.1086\/517472"},{"key":"2025121400191594000_9.10.e027765.39","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181719b60"},{"key":"2025121400191594000_9.10.e027765.40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(89)92282-4","article-title":"Patient-applied podofilox for treatment of genital warts","volume":"333","author":"Beutner","year":"1989","journal-title":"The Lancet"},{"key":"2025121400191594000_9.10.e027765.41","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90424-C"},{"key":"2025121400191594000_9.10.e027765.42","doi-asserted-by":"publisher","DOI":"10.1136\/sti.70.2.105"},{"key":"2025121400191594000_9.10.e027765.43","first-page":"735","article-title":"A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women","volume":"77","author":"Greenberg","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2025121400191594000_9.10.e027765.44","doi-asserted-by":"publisher","DOI":"10.1136\/sti.71.6.387"},{"key":"2025121400191594000_9.10.e027765.45","doi-asserted-by":"publisher","DOI":"10.1258\/0956462961918400"},{"key":"2025121400191594000_9.10.e027765.46","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181f68ebb"},{"key":"2025121400191594000_9.10.e027765.47","unstructured":"Tuncel A , Erbagci MZ , Ozgoztasi O . An open-label comparative study to evaluate the efficacy and tolerability of imiquimod 5% cream alone and combined with cryotherapy in the treatment of recalcitrant anogenital warts. The 14th Congress of the European Academy of Dermatology and Venereology; 2005; London, UK. J Eur Acad Dermtaol Venereol 2005:1\u2013412."},{"key":"2025121400191594000_9.10.e027765.48","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199320060-00008"},{"key":"2025121400191594000_9.10.e027765.49","doi-asserted-by":"publisher","DOI":"10.1136\/sti.66.1.16"},{"key":"2025121400191594000_9.10.e027765.50","first-page":"187","article-title":"2) laser therapy versus cryotherapy in treatment of genital warts; a randomized controlled trial (RCT)","volume":"4","author":"Azizjalali","year":"2012","journal-title":"Iran J Microbiol"},{"key":"2025121400191594000_9.10.e027765.51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1590\/s0102-865020170060000009","article-title":"Argon plasma versus electrofulguration in the treatment of anal and perianal condylomata acuminata in patients with acquired immunodeficiency virus","volume":"32","author":"Braga","year":"2017","journal-title":"Acta Cir. Bras."},{"key":"2025121400191594000_9.10.e027765.52","doi-asserted-by":"publisher","DOI":"10.1089\/gyn.1995.11.41"},{"key":"2025121400191594000_9.10.e027765.53","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-007-9041-2"},{"key":"2025121400191594000_9.10.e027765.54","doi-asserted-by":"publisher","DOI":"10.1136\/sti.64.4.263"},{"key":"2025121400191594000_9.10.e027765.55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/09546639009086712","article-title":"Clinical efficacy of Condyline (0.5% podophyllotoxin) solution and cream versus podophyllin in the treatment of external condylomata acuminata","volume":"1","author":"Mazurkiewicz","year":"1990","journal-title":"J Dermatolog Treat"},{"key":"2025121400191594000_9.10.e027765.56","doi-asserted-by":"publisher","DOI":"10.1258\/095646207781024711"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-027765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:19:26Z","timestamp":1765700366000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-027765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,31]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/bmjopen-2018-027765"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-027765","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}